Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiansheng Wang

Showing results (161-170 of 173) with videos related to

Pageof 18
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 2, 2015
Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitorsMichael J Boyd, Upul K Bandarage, Hamilton Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacyEmanuele Perola, Dean Stamos, Anne-Laure Grillot, et al.
BMC Pediatrics|March 30, 2023
Study on the relationship between obesity and complications of Pediatric Epilepsy surgeryLei Shen, Mengyang Wang, Jingwei Zhao, et al.
Journal of Medicinal Chemistry|June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γPhilip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Mbio|March 8, 2018
Multisystem Analysis of <i>Mycobacterium tuberculosis</i> Reveals Kinase-Dependent Remodeling of the Pathogen-Environment InterfaceXavier Carette, John Platig, David C Young, et al.
Journal of Medicinal Chemistry|October 16, 2014
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liabilityAnne-Laure Grillot, Arnaud Le Tiran, Dean Shannon, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|October 28, 2025
[Chinese expert consensus on the evaluation of allergen-specific immunotherapy outcomes(Wuhan, 2025)]Yuqin Deng, Xi Luo, Zhuofu Liu, et al.
Journal of Medicinal Chemistry|December 18, 2009
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindoleTiansheng Wang, John P Duffy, Jian Wang, et al.
Journal of Medicinal Chemistry|August 12, 2008
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationshipsPaul S Charifson, Anne-Laure Grillot, Trudy H Grossman, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Pageof 18

Showing results (161-170 of 173) with videos related to

Sort By:
Pageof 18
Bioorganic & Medicinal Chemistry Letters|April 2, 2015
Isosteric replacements of the carboxylic acid of drug candidate VX-787: Effect of charge on antiviral potency and kinase activity of azaindole-based influenza PB2 inhibitorsMichael J Boyd, Upul K Bandarage, Hamilton Bennett, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Successful application of serum shift prediction models to the design of dual targeting inhibitors of bacterial gyrase B and topoisomerase IV with improved in vivo efficacyEmanuele Perola, Dean Stamos, Anne-Laure Grillot, et al.
BMC Pediatrics|March 30, 2023
Study on the relationship between obesity and complications of Pediatric Epilepsy surgeryLei Shen, Mengyang Wang, Jingwei Zhao, et al.
Journal of Medicinal Chemistry|June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γPhilip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Mbio|March 8, 2018
Multisystem Analysis of <i>Mycobacterium tuberculosis</i> Reveals Kinase-Dependent Remodeling of the Pathogen-Environment InterfaceXavier Carette, John Platig, David C Young, et al.
Journal of Medicinal Chemistry|October 16, 2014
Second-generation antibacterial benzimidazole ureas: discovery of a preclinical candidate with reduced metabolic liabilityAnne-Laure Grillot, Arnaud Le Tiran, Dean Shannon, et al.
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Journal of Clinical Otorhinolaryngology Head and Neck Surgery|October 28, 2025
[Chinese expert consensus on the evaluation of allergen-specific immunotherapy outcomes(Wuhan, 2025)]Yuqin Deng, Xi Luo, Zhuofu Liu, et al.
Journal of Medicinal Chemistry|December 18, 2009
Janus kinase 2 inhibitors. Synthesis and characterization of a novel polycyclic azaindoleTiansheng Wang, John P Duffy, Jian Wang, et al.
Journal of Medicinal Chemistry|August 12, 2008
Novel dual-targeting benzimidazole urea inhibitors of DNA gyrase and topoisomerase IV possessing potent antibacterial activity: intelligent design and evolution through the judicious use of structure-guided design and structure-activity relationshipsPaul S Charifson, Anne-Laure Grillot, Trudy H Grossman, et al.
ACS Medicinal Chemistry Letters|February 16, 2017
Discovery of Novel, Orally Bioavailable β-Amino Acid Azaindole Inhibitors of Influenza PB2Luc J Farmer, Michael P Clark, Michael J Boyd, et al.
Pageof 18